MedTrace Logo

Dexmedetomidine on Pediatric Heart Operation

NCT01920542 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-11-10

No results posted yet for this study

Summary

we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients

Conditions

  • Acute Renal Injury

Interventions

DRUG

Dexmedetomidine

administration of dexmedetomidine on dexemedetomidine group

DRUG

no dexmedetomidine

no administration of dexmedetomidine on control group

Sponsors & Collaborators

  • Gachon University Gil Medical Center

    lead OTHER

Principal Investigators

  • Kyung Cheon Lee, M.D., Ph.D · Gachon University Gil Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-07-31
Completion
2016-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01920542 on ClinicalTrials.gov